S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6993 −0.01%
PRE-MKT · 05:50 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead

XTNT

Xtant Medical Holdings, Inc.
NYSE · HEALTH CARE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
0.21
+0.00 +0.00%
USD · close Nov 18

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $29.5MP/E —DIV YIELD —FCF YIELD -2.36%REV TTM $109.5M −14.3%NET INCOME −$11.1MNET CASH $2.6M52W 0.21 – 0.81SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$23M−35.0%57.9%−$9.2M−$9.4M−365.2%-0.07−$7.3M$247K−$7.6MAug 11
Q1 2026 · Mar 31$20.9M−36.5%57.3%−$2.9M−$3.1M−5425.9%-0.02−$2.1M$194K−$2.3MAug 11
Q4 2025 · Dec 31derived$32.4M+2.7%54.9%−$944K$57K—0.00$5.4M$395K$5MMar 31
Q3 2025 · Sep 30$33.3M+19.0%66.1%$2.5M$1.3M—0.01$4.6M$430K$4.2MNov 10
Q2 2025 · Jun 30$35.4M+18.3%68.6%$4.6M$3.5M—0.02$1.3M$366K$910KAug 11
Q1 2025 · Mar 31$32.9M+18.0%61.5%$1.1M$58K—0.00$1.3M$1.2M$87KAug 11
Q4 2024 · Dec 31derived$31.5M+12.1%50.8%−$1.9M−$3.2M—-0.02$665K$672K−$7KMar 31
Q3 2024 · Sep 30$27.9M+11.7%58.4%−$3.8M−$5M−154.4%-0.04−$1.7M$2.1M−$3.8MNov 10
Q2 2024 · Jun 30$29.9M—62.1%−$2.9M−$3.9M—-0.03−$5.1M$564K−$5.7MNov 10
Q1 2024 · Mar 31$27.9M—62.1%−$3.5M−$4.4M—-0.03−$5.8M$773K−$6.5MNov 10
Q4 2023 · Dec 31derived$28.1M—61.0%−$3.8M−$4.3M—-0.03−$915K$363K−$1.3MMar 6
Q3 2023 · Sep 30$25M—61.3%−$3.4M$9.2M—0.07−$3.8M$223K−$4.1MNov 12

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$133.9M62.9%$7.3M$5M3.7%0.03$12.5M$2.4M$10.2M——
FY2024 · to Dec 31$117.3M58.2%−$12.1M−$16.4M-14.0%-0.12−$11.9M$4.1M−$16M——
FY2023 · to Dec 31$91.3M60.8%−$10.2M$660K0.7%0.01−$9.5M$1.5M−$11M——
FY2022 · to Dec 31$58M55.4%−$6.8M−$8.5M-14.6%-0.09−$5.3M$1.8M−$7.1M——
FY2021 · to Dec 31$55.3M58.8%−$3.9M−$4.8M-8.8%-0.06$439K$2.1M−$1.7M——
FY2020 · to Dec 31$53.3M64.5%−$751K−$7M-13.2%-0.25−$731K$1.5M−$2.3M——

Every number comes from Xtant Medical Holdings, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch XTNT. Know when insiders buy.
One email the day a filing lands. Free.